A couple of the ARK exchange-traded funds run by ETF star Cathie Wood made huge purchases on Thursday. These funds bought over 1 million shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares on Thursday, as the price of these ETFs rose around 3% on Thursday. Note that these ETFs are still up handily in the last year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 201,664 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 808,642 shares of Iovance. At Thursday’s closing price this would have valued this purchase at $18.9 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 65%, and ARKK is up 75% in the last year.
Check out all of ARK Invest’s buys for Thursday:
|ARKF||COIN||COINBASE GLOBAL INC||38,220|
|ARKG||RXRX||RECURSION PHARMACEUTICALS INC||14,440|
|ARKG||ONEM||1LIFE HEALTHCARE INC||144,563|
|ARKG||SGFY||SIGNIFY HEALTH INC||139,900|
|ARKG||IOVA||IOVANCE BIOTHERAPEUTICS INC||201,664|
|ARKG||CSTL||CASTLE BIOSCIENCES INC||11,536|
|ARKG||CMIIU||CM LIFE SCIENCES II INC||305|
|ARKG||MASS||908 DEVICES INC||13,080|
|ARKG||RPTX||REPARE THERAPEUTICS INC||41,780|
|ARKK||PACB||PACIFIC BIOSCIENCES OF CALIFORNIA INC||7,496|
|ARKK||IOVA||IOVANCE BIOTHERAPEUTICS INC||808,642|
|ARKK||EXAS||EXACT SCIENCES CORP||125,929|
|ARKK||COIN||COINBASE GLOBAL INC||216,518|
|ARKK||BEAM||BEAM THERAPEUTICS INC||30,000|
|ARKQ||ACIC||ATLAS CREST INVESTMENT CORP||421,940|
|ARKX||BLDE||BLADE AIR MOBILITY INC||105,037|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.